The German Keratoplasty Registry of the German Ophthalmological Society (DOG)
Launched by UNIVERSITÄT DES SAARLANDES · Dec 18, 2017
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The German Keratoplasty Registry study is looking at the trends in corneal transplantation, which is a surgery to replace a damaged or diseased cornea (the clear front part of the eye) with a healthy one. This research aims to gather information on how many of these surgeries are being done in Germany, the techniques used, and the reasons for the surgeries. The study is ongoing, and they are currently recruiting participants who have undergone any type of corneal transplant since 2001.
If you or a family member have had a corneal transplant in Germany, you may be eligible to participate in this study. All ages from one year to 100 years are welcome to join, as long as you’ve had a corneal transplant. If you decide to participate, you can expect to provide some information about your surgery and health, which will help researchers understand how these procedures are evolving over time. This study is important for improving future treatments and outcomes for patients needing corneal transplants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients in Germany treated with the different types of corneal transplantation since 2001.
- Exclusion Criteria:
- • Patients without corneal transplantation.
About Universität Des Saarlandes
The Universität des Saarlandes is a distinguished academic institution located in Germany, recognized for its commitment to advancing research and education in the medical and health sciences. As a clinical trial sponsor, the university leverages its robust interdisciplinary expertise and state-of-the-art facilities to facilitate innovative research initiatives aimed at addressing critical health challenges. The institution fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring rigorous adherence to ethical standards and regulatory compliance throughout the clinical trial process. Through its dedication to scientific excellence and patient-centered research, Universität des Saarlandes plays a vital role in contributing to the development of novel therapeutic interventions and improving healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Homburg, Saarland, Germany
Patients applied
Trial Officials
Berthold Seitz, Prof.Dr.med.
Study Director
Universität des Saarlandes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials